Shih-Shan Lang, Jillian Ploof, Natalie J Atkin, Kella Tran-Du, Bhavya M Kanuga, Phillip B Storm, Gregory Heuer, Ian Yuan, Nicholas S Abend, Matthew P Kirschen, Alexis A Topjian, Yimei Li, Angela J Waanders, Joseph J Zorc, Jimmy W Huh
OBJECTIVE: Cerebral ventricular shunt failure is common and presents with symptoms that range from headaches to death. The combination of Diamox (acetazolamide), Decadron (dexamethasone), and Zantac (ranitidine) (DDZ) is used at our institution to medically stabilize pediatric patients presenting with symptomatic shunt failure before shunt revision. We describe our experience of this drug combination as a temporizing measure to decrease symptoms associated with shunt failure. METHODS: We performed a single-center retrospective chart review of patients younger than 18 years with ventricular shunt failure who underwent a shunt revision between January 2015 to October 2017 and received DDZ before surgery...
December 1, 2021: Pediatric Emergency Care